The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients

Overview of attention for article published in Frontiers in Pharmacology, February 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,781 followers.

New Research: The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients https://t.co/s2k8wuqkAF #pharmacology

16 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.